Reauthorization; reporting requirements

Section 744N of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–73) is amended— (1) in subsection (a)— (A) by striking Beginning with fiscal year 2021, and not later than 120 calendar days after the end of each fiscal year thereafter and inserting Not later than 120 calendar days after the end of each fiscal year; and (B) by striking section 3861(b) of the CARES Act and inserting section 2 of the Over-the-Counter Monograph Drug User Fee Amendments; (2) in subsection (b), by striking fiscal year 2021 and each subsequent fiscal year and inserting each fiscal year; and (3) in subsection (d), by striking 2025 each place it appears and inserting 2030.

Section 744N of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 379j–73) is amended— (1) in subsection (a)— (A) by striking Beginning with fiscal year 2021, and not later than 120 calendar days after the end of each fiscal year thereafter and inserting Not later than 120 calendar days after the end of each fiscal year; and (B) by striking section 3861(b) of the CARES Act and inserting section 2 of the Over-the-Counter Monograph Drug User Fee Amendments; (2) in subsection (b), by striking fiscal year 2021 and each subsequent fiscal year and inserting each fiscal year; and (3) in subsection (d), by striking 2025 each place it appears and inserting 2030.